BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao G, Wang X, Edwards S, Dai M, Li J, Wu L, Xu R, Han J, Yuan H. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome. Eur J Pharmacol 2020;881:173276. [PMID: 32574674 DOI: 10.1016/j.ejphar.2020.173276] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun L, Yuan H, Zhao G. IL-37 alleviates Coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis. Sci Rep 2022;12:20077. [DOI: 10.1038/s41598-022-22617-y] [Reference Citation Analysis]
2 Wang X, Rao J, Tan Z, Xun T, Zhao J, Yang X. Inflammatory signaling on cytochrome P450-mediated drug metabolism in hepatocytes. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1043836] [Reference Citation Analysis]
3 Valencia R, Bassiouni W, Darwesh AM, Bapuji R, Seubert JM. Cardiomyocyte-specific CYP2J2 and its therapeutic implications. Expert Opin Drug Metab Toxicol 2022. [PMID: 35997132 DOI: 10.1080/17425255.2022.2114344] [Reference Citation Analysis]
4 Guo F, Meng F, Zhang X, Zeng T. Spermidine inhibits LPS-induced pro-inflammatory activation of macrophages by acting on Nrf2 signaling but not autophagy. Journal of Functional Foods 2022;94:105115. [DOI: 10.1016/j.jff.2022.105115] [Reference Citation Analysis]
5 Tian X, Liu T, Zhu M, Peng J, Cui J, Feng L, Huo X, Yuan J, Ma X. Endoplasmic Reticulum-Targeting Near-Infrared Fluorescent Probe for CYP2J2 Activity and Its Imaging Application in Endoplasmic Reticulum Stress and Tumor. Anal Chem 2022. [PMID: 35770896 DOI: 10.1021/acs.analchem.2c00425] [Reference Citation Analysis]
6 Chen L, Li Y, Zeng S, Duan S, Huang Z, Liang Y. The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages. In Vitro Cell Dev Biol Anim 2022;58:408-18. [PMID: 35513753 DOI: 10.1007/s11626-022-00654-1] [Reference Citation Analysis]
7 Guan X, Zhou W, Li L, Peng Q. Dexmedetomidine Alleviates Hypoxic-Ischemic Brain Damage in Neonatal Rats Through Reducing MicroRNA-134-5p-Mediated NLRX1 Downregulation. Journal of Stroke and Cerebrovascular Diseases 2022;31:106411. [DOI: 10.1016/j.jstrokecerebrovasdis.2022.106411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shi H, Zhou ZM, Zhu L, Chen L, Jiang ZL, Wu XT. Underlying Mechanisms and Related Diseases Behind the Complex Regulatory Role of NOD-Like Receptor X1. DNA Cell Biol 2022. [PMID: 35363060 DOI: 10.1089/dna.2022.0051] [Reference Citation Analysis]
9 Li AP. Drug‐Metabolizing Enzymes and Drug Toxicity. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity 2021. [DOI: 10.1002/9781119171003.ch4] [Reference Citation Analysis]
10 Fekete T, Bencze D, Bíró E, Benkő S, Pázmándi K. Focusing on the Cell Type Specific Regulatory Actions of NLRX1. Int J Mol Sci 2021;22:1316. [PMID: 33525671 DOI: 10.3390/ijms22031316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]